Table 1 Characteristics of the participants (N = 96)
Characteristics | Total ( N = 96) | Clotrimazole (n = 48) | Sertaconazole (n = 48) | p |
|---|---|---|---|---|
Age (y) | 27.4 ± 7.4 | 27.9 ± 7.4 | 27 ± 7.4 | 0.565 |
< 25 | 44 (45.8) | 20 (41.7) | 24 (50.0) | 0.709 |
25–35 | 32 (33.4) | 17 (35.4) | 15 (31.3) | |
> 35 | 20 (20.8) | 11 (22.9) | 9 (18.7) | |
BMI (kg/m2) | 23.6 ± 5.4 | 23.7 ± 6.2 | 23.4 ± 4.5 | 0.818 |
< 23 | 54 (56.3) | 27 (56.3) | 27 (56.3) | 0.940 |
23–25 | 11 (11.4) | 6 (12.4) | 5 (10.4) | |
> 25 | 31 (32.3) | 15 (31.3) | 16 (33.3) | |
Being parous | 25 (26.0) | 15 (31.3) | 10 (20.8) | 0.245 |
GA at diagnosis (wk) | 22.9 ± 6.4 | 23.0 ± 6.8 | 22.8 ± 6.1 | 0.862 |
≤ 20 | 37 (38.5) | 19 (39.6) | 18 (37.5) | 0.834 |
> 20 | 59 (61.5) | 29 (60.4) | 30 (62.5) | |
Presence of vulvar/vaginal itching | 56 (58.3) | 30 (62.5) | 26 (54.2) | 0.408 |
Abnormal vaginal discharge in prior 4 wk | 35 (36.5) | 18 (37.5) | 17 (35.4) | 0.832 |
Fungal infection in other areas | 6 (6.3) | 2 (4.2) | 4 (8.3) | 0.399* |
History of STIs | 12 (12.5) | 7 (14.6) | 5 (10.4) | 0.537 |
VC in prior year | 0.149 | |||
0 | 41 (42.7) | 16 (33.4) | 25 (52.0) | |
1 | 19 (19.8) | 10 (20.8) | 9 (18.8) | |
2 | 36 (37.5) | 22 (45.8) | 14 (29.2) | |